BKYI Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.9M
-10.5%
2.1M
+98.0%
1.1M
-30.1%
1.5M
-8.7%
1.7M
Cost of Revenue
246.0K
-34.6%
376.3K
+38.7%
271.4K
-24.2%
358.0K
-22.9%
464.2K
Gross Profit
1.7M
-5.4%
1.8M
+117.8%
812.4K
-31.8%
1.2M
-3.3%
1.2M
Operating Expenses
2.2M
+14.3%
1.9M
-61.6%
5.0M
+141.1%
2.1M
-10.0%
2.3M
R&D
640.4K
+3.8%
616.9K
-11.2%
694.5K
+1.6%
683.6K
+7.5%
636.0K
SG&A
1.6M
+19.3%
1.3M
-28.4%
1.8M
+30.6%
1.4M
-16.7%
1.7M
Operating Income
-529405
-235.7%
-157713
+96.3%
-4210929
-372.0%
-892190
+17.7%
-1083850
EBITDA
-495286
-954.7%
-46958
+97.3%
-1769493
-129.2%
-772147
+25.0%
-1029936
Net Income
-576852
-181.3%
-205037
+95.2%
-4289156
-344.5%
-964849
+17.4%
-1167396
EPS (Basic)
$-0.56
-180.0%
$-0.20
$-1.50
+25.4%
$-2.01
EPS (Diluted)
$-0.56
-180.0%
$-0.20
$-1.50
+25.4%
$-2.01
Shares (Diluted)
1.0M
+0.2%
1.0M
658.8K
+13.2%
582.1K
BIO-key International (BKYI) — Financials